DrugPatentWatch Database Preview
Details for Patent: 10,143,792
» See Plans and Pricing
Which drugs does patent 10,143,792 protect, and when does it expire?
Patent 10,143,792 protects EVZIO (AUTOINJECTOR) and is included in one NDA.
This patent has thirty-five patent family members in ten countries.
Summary for Patent: 10,143,792
| Title: | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
| Abstract: | Medicament delivery devices for administration of opioid antagonists are described herein. In some embodiments, an apparatus includes a housing, a medicament container disposed within the housing and an energy storage member disposed within the housing. The medicament container is filled with a naloxone composition that includes naloxone or salts thereof, a tonicity-adjusting agent, and a pH adjusting agent, whereby the osmolality of the naloxone composition ranges from about 250-350 mOsm and the pH ranges from about 3-5. The energy storage member is configured to produce a force to deliver the naloxone composition. |
| Inventor(s): | Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlottesville, VA), Licata; Mark J. (Doswell, VA), Blondino; Frank E. (Henrico, VA) |
| Assignee: | kaleo, Inc. (Richmond, VA) |
| Application Number: | 15/331,073 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,143,792 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Device; Dosage form; |
Drugs Protected by US Patent 10,143,792
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,143,792
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011218756 | Start Trial | |||
| Australia | 2012211307 | Start Trial | |||
| Australia | 2012211320 | Start Trial | |||
| Australia | 2015255197 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
